SurrogateEndpointClinicalStudyReport(CSR)RandomizationDataManagementMulticenterTrialInformedConsentDropoutRatePatientRecruitmentGoodClinicalPractice(GCP)RegulatoryAuthorityFollow-up VisitTrialRegistryInstitutionalReviewBoard(IRB)InvestigatorMeetingClinicalEndpointRecruitmentTargetProtocolPhaseIIScreeningVisitTrialMonitorClinicalResearchCoordinatorPilotStudyCrossoverStudyEndpointParallelStudyCaseReportForm(CRF)StandardOperatingProcedure(SOP)EfficacyPhaseIIIStatisticalAnalysisPlan(SAP)AuditTrailAdverseEventAdaptiveDesignOpen-LabelTrialProtocolDeviationEthicsCommitteeSafetyProfileControlGroupSponsorPlaceboDouble-BlindStudyPhaseISourceDataVerificationEligibilityCriteriaPrincipalInvestigatorBlindingData SafetyMonitoringBoard(DSMB)DataLockPhaseIVInterventionSurrogateEndpointClinicalStudyReport(CSR)RandomizationDataManagementMulticenterTrialInformedConsentDropoutRatePatientRecruitmentGoodClinicalPractice(GCP)RegulatoryAuthorityFollow-up VisitTrialRegistryInstitutionalReviewBoard(IRB)InvestigatorMeetingClinicalEndpointRecruitmentTargetProtocolPhaseIIScreeningVisitTrialMonitorClinicalResearchCoordinatorPilotStudyCrossoverStudyEndpointParallelStudyCaseReportForm(CRF)StandardOperatingProcedure(SOP)EfficacyPhaseIIIStatisticalAnalysisPlan(SAP)AuditTrailAdverseEventAdaptiveDesignOpen-LabelTrialProtocolDeviationEthicsCommitteeSafetyProfileControlGroupSponsorPlaceboDouble-BlindStudyPhaseISourceDataVerificationEligibilityCriteriaPrincipalInvestigatorBlindingData SafetyMonitoringBoard(DSMB)DataLockPhaseIVIntervention

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Surrogate Endpoint
  2. Clinical Study Report (CSR)
  3. Randomization
  4. Data Management
  5. Multicenter Trial
  6. Informed Consent
  7. Dropout Rate
  8. Patient Recruitment
  9. Good Clinical Practice (GCP)
  10. Regulatory Authority
  11. Follow-up Visit
  12. Trial Registry
  13. Institutional Review Board (IRB)
  14. Investigator Meeting
  15. Clinical Endpoint
  16. Recruitment Target
  17. Protocol
  18. Phase II
  19. Screening Visit
  20. Trial Monitor
  21. Clinical Research Coordinator
  22. Pilot Study
  23. Crossover Study
  24. Endpoint
  25. Parallel Study
  26. Case Report Form (CRF)
  27. Standard Operating Procedure (SOP)
  28. Efficacy
  29. Phase III
  30. Statistical Analysis Plan (SAP)
  31. Audit Trail
  32. Adverse Event
  33. Adaptive Design
  34. Open-Label Trial
  35. Protocol Deviation
  36. Ethics Committee
  37. Safety Profile
  38. Control Group
  39. Sponsor
  40. Placebo
  41. Double-Blind Study
  42. Phase I
  43. Source Data Verification
  44. Eligibility Criteria
  45. Principal Investigator
  46. Blinding
  47. Data Safety Monitoring Board (DSMB)
  48. Data Lock
  49. Phase IV
  50. Intervention